NCT01864538 2025-05-11A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced MelanomaImmunoGenesisPhase 2 Terminated11 enrolled 8 charts
NCT02255110 2018-12-14A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue SarcomaMerck KGaA, Darmstadt, GermanyPhase 2 Terminated6 enrolled 6 charts